Chief Financial Officer
A 30-year veteran of life sciences companies, Mr. Eric Winzer has addressed a wide array of financial issues including raising capital, financial reporting, investor relations, banking, taxation, mergers and acquisitions to financial planning, analysis and accounting operations.
Prior to joining Immunomic Therapeutics, he served as chief financial officer of OpGen where he was responsible for all financial functions at the Company. Previously, Mr. Winzer served as executive vice president and chief financial officer for Avalon Pharmaceuticals, Inc., a biotechnology Company developing targeted therapeutics for oncology. Eric also worked at Life Technologies, a provider of life science technologies for disease research and drug discovery, where he held numerous positions in the finance organization including chief financial officer. Currently, Mr. Winzer also serves as director and audit committee chair at Nuo Therapeutics, Inc. (previously Cytomedix, Inc.) He received his B.A. in economics and business administration from McDaniel College and an M.B.A. from Mount Saint Mary’s University.